IE
PRME icon

Israel Englander’s Prime Medicine PRME Stock Holding History

Israel Englander’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
+427,097
New +$1.42M ﹤0.01% 3996
2026
Q1 		– Sell
-51,335
Closed -$178K – 6243
2025
Q4 		$178K Sell
51,335
-1,367,128
-96% -$6.08M ﹤0.01% 5499
2025
Q3 		$7.86M Buy
1,418,463
+1,270,467
+858% +$5.16M ﹤0.01% 2637
2025
Q2 		$366K Sell
147,996
-1,631,949
-92% -$2.52M ﹤0.01% 5086
2025
Q1 		$3.54M Sell
1,779,945
-94,626
-5% -$241K ﹤0.01% 3209
2024
Q4 		$5.47M Sell
1,874,571
-323,669
-15% -$1.14M ﹤0.01% 2738
2024
Q3 		$8.51M Buy
2,198,240
+867,313
+65% +$4.02M ﹤0.01% 2342
2024
Q2 		$6.84M Buy
1,330,927
+895,610
+206% +$5.43M ﹤0.01% 2421
2024
Q1 		$3.05M Buy
435,317
+300,773
+224% +$2.28M ﹤0.01% 3347
2023
Q4 		$1.19M Buy
+134,544
New +$1.04M ﹤0.01% 4015
2023
Q3 		– Sell
-256,560
Closed -$3.76M – 6459
2023
Q2 		$3.76M Buy
256,560
+245,801
+2,285% +$3.43M ﹤0.01% 2921
2023
Q1 		$132K Buy
+10,759
New +$175K ﹤0.01% 5324

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Israel Englander's PRME Position: Q2 2026 in Review

Israel Englander opened a new position in Prime Medicine (PRME) in Q2 2026: 427,097 shares worth $1.58M. The stake represents ﹤0.01% of the portfolio and ranks #3996 among its holdings. This is a return to the name: Israel Englander previously reported a position in PRME as recently as Q4 2025.

Israel Englander first reported a position in PRME in Q1 2023 and has held it in 12 quarters since. The position peaked at $8.51M in Q3 2024. 186 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Israel Englander held 427,097 shares of Prime Medicine worth $1.58M as of Q2 2026.
  • Prime Medicine was a new Israel Englander position in Q2 2026.
  • Prime Medicine made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3996 holding.
  • Israel Englander first reported a position in Prime Medicine in Q1 2023 and has held it in 12 quarters since.
  • Israel Englander's Prime Medicine position peaked at $8.51M in Q3 2024.
  • 186 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.